| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |